• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

当代冠状动脉药物洗脱和涂层支架：最新迷你综述（2023 年）。

Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023).

机构信息

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan.

出版信息

Cardiovasc Interv Ther. 2024 Jan;39(1):15-17. doi: 10.1007/s12928-023-00954-7. Epub 2023 Sep 1.

DOI:10.1007/s12928-023-00954-7
PMID:37656338
Abstract

Percutaneous coronary intervention has become a standard-of-care procedure in patients with acute and chronic coronary syndromes, in which coronary stent technology is commonly used. In this updated mini-review article, we list and summarize the characteristics of contemporary coronary drug-eluting and coated stents in 2023.

摘要

经皮冠状动脉介入治疗已成为急性和慢性冠状动脉综合征患者的标准治疗方法，其中冠状动脉支架技术被广泛应用。在这篇最新的小型综述文章中，我们列出并总结了 2023 年当代冠状动脉药物洗脱和涂层支架的特点。

相似文献

1
Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023).当代冠状动脉药物洗脱和涂层支架：最新迷你综述（2023 年）。
Cardiovasc Interv Ther. 2024 Jan;39(1):15-17. doi: 10.1007/s12928-023-00954-7. Epub 2023 Sep 1.
2
Contemporary coronary drug-eluting and coated stents: a mini-review.当代冠状动脉药物洗脱和涂层支架：小型综述。
Cardiovasc Interv Ther. 2021 Jan;36(1):20-22. doi: 10.1007/s12928-020-00731-w. Epub 2020 Nov 10.
3
Safety and effectiveness of zotarolimus-eluting stents for percutaneous coronary intervention: a systematic review.佐他莫司洗脱支架用于经皮冠状动脉介入治疗的安全性和有效性：一项系统评价。
Future Cardiol. 2018 May 1;14(3):251-267. doi: 10.2217/fca-2017-0091. Epub 2018 Feb 16.
4
Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy.当代药物洗脱支架平台：设计、安全性与临床疗效
Interv Cardiol Clin. 2016 Jul;5(3):331-347. doi: 10.1016/j.iccl.2016.02.003. Epub 2016 Jun 21.
5
Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy.当代药物洗脱支架平台：设计、安全性与临床疗效
Cardiol Clin. 2017 May;35(2):281-296. doi: 10.1016/j.ccl.2016.12.010.
6
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.一年随访期内生物可降解聚合物生物雷帕霉素洗脱支架与耐用聚合物依维莫司洗脱支架的比较：一项基于注册登记的队列研究。
Tex Heart Inst J. 2016 Apr 1;43(2):126-30. doi: 10.14503/THIJ-14-4997. eCollection 2016 Apr.
7
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?支架技术的最新进展：它们是否降低心血管事件？
Curr Atheroscler Rep. 2022 Sep;24(9):731-744. doi: 10.1007/s11883-022-01049-z. Epub 2022 Jul 11.
8
Percutaneous coronary intervention: balloons, stents and scaffolds.经皮冠状动脉介入治疗：球囊、支架和支架。
Clin Res Cardiol. 2018 Aug;107(Suppl 2):55-63. doi: 10.1007/s00392-018-1328-x. Epub 2018 Jul 23.
9
Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.左主干疾病的经皮冠状动脉介入治疗：EXCEL（评价依维莫司洗脱支架 XIENCE 与冠状动脉旁路移植术治疗左主干血运重建效果）和 NOBLE（北欧-波罗的海-英国左主干血运重建研究）时代之前和之后。
Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.117.004792.
10
Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.光学相干断层扫描观察无保护左主干病变后左旋支开口处西罗莫司洗脱支架与依维莫司洗脱支架血管反应的差异
Int J Cardiol. 2017 Mar 1;230:284-292. doi: 10.1016/j.ijcard.2016.12.122. Epub 2016 Dec 23.

引用本文的文献

1
Clinical Review of Cardiogenic Shock After Acute Myocardial Infarction　- Revascularization, Mechanical Circulatory Support, and Beyond.急性心肌梗死后心源性休克的临床综述——血运重建、机械循环支持及其他。
Circ Rep. 2024 Nov 29;7(1):6-14. doi: 10.1253/circrep.CR-24-0141. eCollection 2025 Jan 10.
2
Diagnostic Ability of Risk Models in the Field of Ischemic Stroke for Predicting Atherosclerotic Outcomes in Patients with Acute Myocardial Infarction.缺血性卒中领域风险模型对急性心肌梗死患者动脉粥样硬化结局的预测诊断能力。
J Atheroscler Thromb. 2025 Jul 1;32(7):853-862. doi: 10.5551/jat.65162. Epub 2024 Dec 26.
3

本文引用的文献

1
Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention.支架相关不良事件 >1 年经皮冠状动脉介入治疗后。
J Am Coll Cardiol. 2020 Feb 18;75(6):590-604. doi: 10.1016/j.jacc.2019.11.058.
2
Five-year clinical efficacy and safety of contemporary thin-strut biodegradable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis of 9 randomized controlled trials.当代薄支柱可生物降解聚合物与耐用聚合物药物洗脱支架的五年临床疗效和安全性：9项随机对照试验的系统评价和荟萃分析
Cardiovasc Interv Ther. 2020 Jul;35(3):250-258. doi: 10.1007/s12928-019-00613-w. Epub 2019 Aug 17.
3
Effectiveness of the repeated 3-time-balloon-inflation method in reducing coronary stent edge dissection.
重复三次球囊扩张法在减少冠状动脉支架边缘夹层形成中的有效性。
Heart Vessels. 2024 Dec 24. doi: 10.1007/s00380-024-02510-6.
4
Current situation and overview of resorbable magnesium scaffolds: a perspective for overcoming the remaining issues of polymeric bioresorbable scaffold.可吸收镁支架的现状与概述：克服聚合物生物可吸收支架遗留问题的展望
Cardiovasc Interv Ther. 2025 Apr;40(2):245-254. doi: 10.1007/s12928-024-01070-w. Epub 2024 Dec 21.
5
Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review.经皮冠状动脉介入治疗后房颤患者的抗栓管理：一项临床综述。
J Arrhythm. 2024 Aug 8;40(5):1108-1114. doi: 10.1002/joa3.13128. eCollection 2024 Oct.
6
Impact of Cancer, Inflammation, and No Standard Risk Factors in Patients With Myocardial Infarction.癌症、炎症及无标准风险因素对心肌梗死患者的影响
JACC Asia. 2024 May 28;4(7):507-516. doi: 10.1016/j.jacasi.2024.03.008. eCollection 2024 Jul.
7
Association between Estimated Small Dense Low-Density Lipoprotein Cholesterol and Occurrence of New Lesions after Percutaneous Coronary Intervention in Japanese Patients with Stable Angina and Receiving Statin Therapy.日本稳定型心绞痛且接受他汀类药物治疗的患者中，估计的小而密低密度脂蛋白胆固醇与经皮冠状动脉介入治疗后新病变发生之间的关联。
Rev Cardiovasc Med. 2024 Jun 17;25(6):218. doi: 10.31083/j.rcm2506218. eCollection 2024 Jun.
8
Differential Prognostic Impact of Risk-Prediction Models for Heart Failure in Acute Myocardial Infarction: The Original and Revised Heart Failure Time-Points.急性心肌梗死中心力衰竭风险预测模型的差异预后影响：原始和修订的心力衰竭时间点
J Clin Med. 2024 Apr 24;13(9):2501. doi: 10.3390/jcm13092501.
9
Diagnostic Ability of Manual Calcification Length Assessment on Non-Electrocardiographically Gated Computed Tomography for Estimating the Presence of Coronary Artery Disease.非心电图门控计算机断层扫描手动钙化长度评估对冠状动脉疾病存在情况的诊断能力
J Clin Med. 2024 Apr 12;13(8):2255. doi: 10.3390/jcm13082255.
10
Drug intervention as an emerging concept for secondary prevention in patients with coronary disease.药物干预作为冠心病二级预防的一个新兴概念。
Cardiovasc Interv Ther. 2024 Jul;39(3):223-233. doi: 10.1007/s12928-024-00994-7. Epub 2024 Apr 8.
Impact of strut thickness and number of crown and connectors on clinical outcomes on patients treated with second-generation drug eluting stent.
第二代药物洗脱支架治疗患者中，支柱厚度、冠部数量及连接件对临床结局的影响。
Catheter Cardiovasc Interv. 2020 Dec;96(7):1417-1422. doi: 10.1002/ccd.28228. Epub 2019 Apr 13.
4
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.新一代超小径药物洗脱支架与上一代较厚支架药物洗脱支架治疗冠状动脉疾病的比较。
Circulation. 2018 Nov 13;138(20):2216-2226. doi: 10.1161/CIRCULATIONAHA.118.034456.
5
Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.日本-美国联合随机多中心研究评估 Orbivneich 的 Combo StEnt（日本-美国 HARMONEE）研究：内皮祖细胞捕获和药物洗脱支架联合治疗缺血性冠心病和非 ST 段抬高型急性冠状动脉综合征患者的关键注册研究的主要结果。
Eur Heart J. 2018 Jul 7;39(26):2460-2468. doi: 10.1093/eurheartj/ehy275.
6
Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents.随机临床试验的荟萃分析比较可生物降解聚合物药物洗脱支架与第二代耐用聚合物药物洗脱支架。
JACC Cardiovasc Interv. 2017 Mar 13;10(5):462-473. doi: 10.1016/j.jcin.2016.12.002.
7
Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model.在猪冠状动脉模型中比较耐久性和生物可降解聚合物药物洗脱支架的血管反应。
EuroIntervention. 2014 Oct;10(6):717-23. doi: 10.4244/EIJV10I6A124.